David S. Cunningham's most recent trade in Immucell Corp. was a trade of 10,000 Non Qualified Stock Options (Right to buy) done . Disclosure was reported to the exchange on Dec. 15, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immucell Corp | David S. Cunningham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 10,000 | 10,000 | - | - | Non Qualified Stock Options (Right to buy) | |
| Immucell Corp | David S. Cunningham | Director | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 13 Jun 2022 | 1,000 | 16,000 (0%) | 0% | 8 | 8,000 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Cunningham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 10,000 | 10,000 | - | - | Incentive Stock Options (Right to buy) |